Journal of Dermatology

Papers
(The H4-Index of Journal of Dermatology is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Vitiligo: A focus on pathogenesis and its therapeutic implications86
Psoriasis: Comorbidities70
Basics and recent advances in the pathophysiology of atopic dermatitis69
Pathophysiology of psoriasis: A review58
Development of a light‐weight deep learning model for cloud applications and remote diagnosis of skin cancers55
Alopecia areata: Current understanding of the pathophysiology and update on therapeutic approaches, featuring the Japanese Dermatological Association guidelines40
Psoriasis: Recent progress in molecular‐targeted therapies39
Real life experience of apremilast in psoriasis and arthritis psoriatic patients: Preliminary results on metabolic biomarkers34
Clinical characteristics and health‐care resource utilization in patients with generalized pustular psoriasis using real‐world evidence from the Japanese Medical Data Center database31
Patient characteristics and burden of disease in Japanese patients with generalized pustular psoriasis: Results from the Medical Data Vision claims database30
Epidemiological study of terbinafine‐resistant dermatophytes isolated from Japanese patients30
Epidemiological survey of the psoriasis patients in the Japanese Society for Psoriasis Research from 2013 to 201827
Guidelines for the management of dermatomycosis (2019)24
The efficacy and safety of upadacitinib treatment for moderate to severe atopic dermatitis in real‐world practice in Japan24
Similarity and difference between palmoplantar pustulosis and pustular psoriasis22
Clinical characteristics of Japanese pustular psoriasis: A multicenter observational study22
Current status of Panton–Valentine leukocidin‐positive methicillin‐resistant Staphylococcus aureus isolated from patients with skin and soft tissue infections in Japan22
Real‐world effectiveness of guselkumab in patients with psoriasis: Health‐related quality of life and efficacy data from the noninterventional, prospective, German multicenter PERSIST trial22
Role of necroptosis in infection‐related, immune‐mediated, and autoimmune skin diseases22
Higher baseline serum lactate dehydrogenase level is associated with poor effectiveness of dupilumab in the long term in patients with atopic dermatitis21
Diversity analysis of gut microbiota between healthy controls and those with atopic dermatitis in a Chinese population21
0.077631950378418